XTLB

XTL Biopharmaceuticals (XTLB)

XTL Biopharmaceuticals Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:XTLB

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/20	07 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2024/11/12	23 : 15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2024/10/15	22 : 12	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2024/08/14	22 : 15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2024/08/14	22 : 15	GlobeNewswire Inc.	XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2024/07/23	05 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2024/06/13	05 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2024/06/05	22 : 20	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2024/06/05	22 : 15	GlobeNewswire Inc.	XTL Entered Definitive Agreement to Acquire The Social Proxy	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2024/05/13	23 : 32	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2024/03/20	23 : 15	GlobeNewswire Inc.	XTL To Aquire The Social Proxy	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/11/16	00 : 29	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/10/21	05 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/10/21	05 : 00	GlobeNewswire Inc.	XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/10/21	05 : 00	GlobeNewswire Inc.	XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/08/10	22 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/05/17	00 : 01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/02/24	04 : 30	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2023/02/01	23 : 53	Edgar (US Regulatory)	Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2022/08/24	23 : 31	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2022/03/31	06 : 16	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2022/01/27	02 : 43	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2022/01/20	01 : 04	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/12/17	07 : 17	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/11/25	00 : 39	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/06/08	19 : 05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/05/20	00 : 40	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/05/20	00 : 31	Edgar (US Regulatory)	Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/05/20	00 : 26	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd
2021/01/07	23 : 10	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:XTLB	XTL Biopharmaceuticals Ltd